USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140205583A1
SERIAL NO

14162655

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to methods of modifying pyridoxal 5′ phosphate (PLP) dependent enzymes to extend the serum half-life of the enzyme, extend the in vivo period of methionine depletion in a host, and decrease the immunogenicity of the enzyme. A preferred PLP-dependent enzyme to be modified is a methioninase, preferably a recombinant methioninase (rMETase). The invention further relates to compositions comprising a modified PLP-dependent enzyme and methods of using the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ANTICANCER INCCALIFORNIA USA CALIFORNIA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
LI, Shukuan San Diego, US 11 36
SUN, Xinghua San Diego, US 30 88
TAN, Yuying San Diego, US 42 330
YAGI, Shigeo San Diego, US 20 104
YANG, Zhijian San Diego, US 52 447

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation